Neurovascular Device Market to Reach USD 6.04 Billion by 2031 | SkyQuest Technology

WESTFORD, Mass. - Aug. 14, 2024 - PRLog -- SkyQuest projects that the Neurovascular Device Market will attain a value of USD 6.04 Billion by 2031, with a CAGR of 8.5 % during the forecast period (2024-2031).  The neurovascular devices market is boosted by the growing prevalence of neurological diseases, technological advancement, and rising demand for minimally invasive processes. In recent times, many people are suffering from neurological diseases like brain aneurysm, strokes, and epilepsy, and this is resulting in a significant rise in demand for neurovascular devices. Another disease contributing to the growth of the market is acute ischemic stroke. The popularity of minimally invasive surgeries is also increasing because of the decreases risk and trauma related to these processes. Postoperative pain can be reduced with smaller incisions leading to speedy recovery.

Increasing Awareness about Neurological Disorders Promotes Neurovascular Devices North America Boosting Market Growth

North America accounts for the dominant market share of neurovascular devices. This can be attributed to factors like increased awareness of neurological disorders, growing geriatric population, and advanced medical care infrastructure. There are also many key players present in the region creating developmental strategies to boost market growth. The market of the Asia-Pacific region is also growing rapidly due to huge population and increasing expenditure on advanced healthcare systems. Rise in disposable is also positively influencing the market as it is encouraging the adoption of neurovascular devices.

Request For Report Sample: https://www.skyquestt.com/sample-request/neurovascular-de...

Neurovascular Devices Market Insights
Drivers:

• Strategic partnerships among key market players to increase the demand for the neurovascular device with advanced products.
• Rising geriatric population to create lucrative opportunities for the market.
• Emphasis on patient outcome and quality of life is a major factor contributing to the growth.
• Better reimbursement policies are accelerating the demand for neurovascular devices.  

Restraints:

• Strict regulations are an important factor that is decreasing the viability of the market
• High expense of neurovascular processes is restraining the market growth
• Very less access to advanced healthcare facilities, especially in developing regions can be a challenge
• High risk of complications and adverse events can impede the development of the market

Key Players in Neurovascular Market

• Acandis GmbH
• Asahi Intecc Co. Ltd.
• Imperative Care Inc.
• Integer Holdings Corporation
• Johnson & Johnson
• Medtronic plc
• MicroPort Scientific Corporation
• Penumbra Inc.
• Perflow Medical Ltd.
• Rapid Medical
• Stryker Corporation  

Key Questions Answered in the Neurovascular Market

• Which are the key players of the neurovascular Market?
• What are the critical drivers of the market?
• Which region is leading the neurovascular market?
• What is neurovascular market growth?.  

Visit Full Report Analysis: https://www.skyquestt.com/report/neurovascular-devices-ma...